Literature DB >> 13821638

Use of spironolactone and hydrochlorothiazide in treatment of oedema.

R O FARRELLY, R N HOWIE, J D NORTH.   

Abstract

Entities:  

Keywords:  ALDOSTERONE/antagonists; CHLOROTHIAZIDE/related compounds; DIURETICS/therapy; EDEMA/therapy

Mesh：

Substances：

Year:  1960        PMID： 13821638      PMCID： PMC2097506          DOI： 10.1136/bmj.2.5195.339

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  15 in total

1.  Isolation of crystalline aldosterone from the urine of a nephrotic patient.

Authors:  J A LUETSCHER; R NEHER; A WETTSTEIN
Journal:  Experientia       Date:  1954-11-15

2.  The use of a steroidal spirolactone in the treatment of ascites in hepatic cirrhosis.

Authors:  D N KERR; A E READ; R M HASLAM; S SHERLOCK
Journal:  Lancet       Date:  1958-11-22       Impact factor: 79.321

3.  Antagonism between the effect of aldosterone and a synthetic steroid lactone on the renal excretion of sodium and potassium in man.

Authors:  E J ROSS; J E BETHUNE
Journal:  Lancet       Date:  1959-01-17       Impact factor: 79.321

4.  Studies on new diuretic compounds: spirolactone and chlorothiazide.

Authors:  E BOLTE; M VERDY; J MARC-AURELE; J BROUILLET; P BEAUREGARD; J GENEST
Journal:  Can Med Assoc J       Date:  1958-12-01       Impact factor: 8.262

5.  [Not Available].

Authors:  J T AUGUST; D H NELSON; G W THORN
Journal:  N Engl J Med       Date:  1958-11-13       Impact factor: 91.245

6.  Total exchangeable sodium, total exchangeable potassium, and total body water in edematous patients with cirrhosis of the liver and congestive heart failure.

Authors:  L W BIRKENFELD; J LEIBMAN; M P O'MEARA; I S EDELMAN
Journal:  J Clin Invest       Date:  1958-05       Impact factor: 14.808

7.  Aldosterone excretion in patients with cirrhosis of the liver.

Authors:  I DYRENFURTH; C H STACEY; J C BECK; E H VENNING
Journal:  Metabolism       Date:  1957-11       Impact factor: 8.694

8.  Effect of an aldosterone antagonist on sodium and potassium excretion in primary hyperaldosteronism.

Authors:  R M SALASSA; V R MATTOX; M H POWER
Journal:  J Clin Endocrinol Metab       Date:  1958-07       Impact factor: 5.958

9.  The effect of changes in body sodium on extracellular fluid volume and aldosterone and sodium excretion by normal and edematous men.

Authors:  F C BARTTER; L E DUNCAN; G W LIDDLE
Journal:  J Clin Invest       Date:  1956-11       Impact factor: 14.808

10.  Excretion of sodium-retaining substances in patients with congestive heart failure.

Authors:  B SINGER; J WENER
Journal:  Am Heart J       Date:  1953-06       Impact factor: 4.749
View more
  4 in total

1.  Diuretic response to chlorthalidone.

Authors:  A DOUGLAS; R HALL; D B HORN; D N KERR; D T PEARSON; H RICHARDSON
Journal:  Br Med J       Date:  1961-07-22

2.  Spironolactone.

Authors: 
Journal:  Br Med J       Date:  1967-06-17

3.  Spironolactone (Aldactone) therapy for ascites due to cirrhosis of the liver.

Authors:  C H LOCKWOOD
Journal:  Can Med Assoc J       Date:  1961-09-09       Impact factor: 8.262

4.  Metabolic studies on patients with resistant heart failure treated by spironolactone.

Authors:  T A BAYLEY; P G FORBATH; J K WILSON; H P HIGGINS
Journal:  Can Med Assoc J       Date:  1962-12-15       Impact factor: 8.262
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.